These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

949 related articles for article (PubMed ID: 20805891)

  • 1. Cancer biomarker discovery: the entropic hallmark.
    Berretta R; Moscato P
    PLoS One; 2010 Aug; 5(8):e12262. PubMed ID: 20805891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative analysis reveals disease-associated genes and biomarkers for prostate cancer progression.
    Li Y; Vongsangnak W; Chen L; Shen B
    BMC Med Genomics; 2014; 7 Suppl 1(Suppl 1):S3. PubMed ID: 25080090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative network measures as biomarkers for classifying prostate cancer disease states: a systems approach to diagnostic biomarkers.
    Dehmer M; Mueller LA; Emmert-Streib F
    PLoS One; 2013; 8(11):e77602. PubMed ID: 24236006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological network signatures of cancer progression and survival.
    Clancy T; Pedicini M; Castiglione F; Santoni D; Nygaard V; Lavelle TJ; Benson M; Hovig E
    BMC Med Genomics; 2011 Mar; 4():28. PubMed ID: 21453479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarrays--identifying molecular portraits for prostate tumors with different Gleason patterns.
    Mendes A; Scott RJ; Moscato P
    Methods Mol Med; 2008; 141():131-51. PubMed ID: 18453088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A probabilistic approach for automated discovery of perturbed genes using expression data from microarray or RNA-Seq.
    Sundaramurthy G; Eghbalnia HR
    Comput Biol Med; 2015 Dec; 67():29-40. PubMed ID: 26492320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-platform comparison and visualisation of gene expression data using co-inertia analysis.
    Culhane AC; Perrière G; Higgins DG
    BMC Bioinformatics; 2003 Nov; 4():59. PubMed ID: 14633289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathways involved in prostate carcinogenesis: insights from public microarray datasets.
    Baetke SC; Adriaens ME; Seigneuric R; Evelo CT; Eijssen LM
    PLoS One; 2012; 7(11):e49831. PubMed ID: 23185449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women.
    Colak D; Nofal A; Albakheet A; Nirmal M; Jeprel H; Eldali A; Al-Tweigeri T; Tulbah A; Ajarim D; Malik OA; Inan MS; Kaya N; Park BH; Bin Amer SM
    PLoS One; 2013; 8(5):e63204. PubMed ID: 23704896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.
    Rubin MA; Zhou M; Dhanasekaran SM; Varambally S; Barrette TR; Sanda MG; Pienta KJ; Ghosh D; Chinnaiyan AM
    JAMA; 2002 Apr; 287(13):1662-70. PubMed ID: 11926890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression.
    Prensner JR; Iyer MK; Balbin OA; Dhanasekaran SM; Cao Q; Brenner JC; Laxman B; Asangani IA; Grasso CS; Kominsky HD; Cao X; Jing X; Wang X; Siddiqui J; Wei JT; Robinson D; Iyer HK; Palanisamy N; Maher CA; Chinnaiyan AM
    Nat Biotechnol; 2011 Jul; 29(8):742-9. PubMed ID: 21804560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling gene expression profiles related to prostate tumor progression using binary states.
    Martinez E; Trevino V
    Theor Biol Med Model; 2013 May; 10():37. PubMed ID: 23721350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
    Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSEH: A Novel Approach to Select Prostate Cancer-Associated Genes Using Gene Expression Heterogeneity.
    Kim H; Choi SM; Park S
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(1):129-146. PubMed ID: 27775535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GWAS meets microarray: are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an example.
    Gorlov IP; Gallick GE; Gorlova OY; Amos C; Logothetis CJ
    PLoS One; 2009 Aug; 4(8):e6511. PubMed ID: 19652704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haploinsufficiency and reduced expression of genes localized to the 8p chromosomal region in human prostate tumors.
    Chaib H; MacDonald JW; Vessella RL; Washburn JG; Quinn JE; Odman A; Rubin MA; Macoska JA
    Genes Chromosomes Cancer; 2003 Jul; 37(3):306-13. PubMed ID: 12759929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using molecular markers to predict outcome.
    Rubin MA
    J Urol; 2004 Nov; 172(5 Pt 2):S18-21; discussion S21-2. PubMed ID: 15535437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inference of combinatorial Boolean rules of synergistic gene sets from cancer microarray datasets.
    Park I; Lee KH; Lee D
    Bioinformatics; 2010 Jun; 26(12):1506-12. PubMed ID: 20410052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of the top-scoring pairs of genes for prediction of prostate cancer progression.
    Zhao H; Logothetis CJ; Gorlov IP
    Prostate Cancer Prostatic Dis; 2010 Sep; 13(3):252-9. PubMed ID: 20386565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CoGA: An R Package to Identify Differentially Co-Expressed Gene Sets by Analyzing the Graph Spectra.
    Santos Sde S; Galatro TF; Watanabe RA; Oba-Shinjo SM; Nagahashi Marie SK; Fujita A
    PLoS One; 2015; 10(8):e0135831. PubMed ID: 26313749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.